McKesson (MCK) is a 'Buy' with high-growth potential in healthcare services. Learn key risks and outlook for stock ...

McKesson (MCK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

McKesson is moving forward with a planned spin-off of its Medical-Surgical Solutions business, aiming to bring both organizations into “sharper focus.” ...

McKesson (MCK) stock earns a BUY rating as it excels in tech-driven healthcare, specialty growth, and strong earnings ...

McKesson's fair value estimate has been raised from $793.21 to $829.57, driven by an improved outlook from analysts following ...

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2025 third quarter financial results. Results can be accessed on McKesson’s ...

McKesson (MCK) delivered its latest quarterly results, reporting a 23% rise in revenue, a 15% higher dividend, and an upward ...

McKesson's acquisition of FCS' Core Ventures integrates FCS into The US Oncology Network, expanding its reach to over 700 locations and 1.5 million patients annually. The consolidation trend in ...

Following the announcement of the updated organizational structure, McKesson is initiating long-term Adjusted Segment Operating Profit growth targets for its newly defined segments, as follows: ...

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2025 second quarter financial results. Results can be accessed on McKesson ...